Lisa Deloch

1.4k total citations
31 papers, 991 citations indexed

About

Lisa Deloch is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Lisa Deloch has authored 31 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 10 papers in Immunology. Recurrent topics in Lisa Deloch's work include Effects of Radiation Exposure (14 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (7 papers). Lisa Deloch is often cited by papers focused on Effects of Radiation Exposure (14 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (7 papers). Lisa Deloch collaborates with scholars based in Germany, Australia and United States. Lisa Deloch's co-authors include Udo S. Gaipl, Benjamin Frey, Rainer Fietkau, Anja Derer, Michael Rückert, Paul F. Rühle, Rainer Fietkau, Yvonne Rubner, Markus Hecht and Josefin Hartmann and has published in prestigious journals such as Journal of Hazardous Materials, International Journal of Molecular Sciences and Immunological Reviews.

In The Last Decade

Lisa Deloch

25 papers receiving 986 citations

Peers

Countries citing papers authored by Lisa Deloch

Since Specialization

Citations

This map shows the geographic impact of Lisa Deloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Deloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Deloch more than expected).

Fields of papers citing papers by Lisa Deloch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Deloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Deloch. The network helps show where Lisa Deloch may publish in the future.

Co-authorship network of co-authors of Lisa Deloch

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Deloch. A scholar is included among the top collaborators of Lisa Deloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Deloch. Lisa Deloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing offline magnetic resonance-guided prostate radiotherapy through dedicated imaging and deep learning-based automatic contouring of targets and neurovascular structures 2025 ·Physics and Imaging in Radiation Oncology ·Philipp Schubert, Matthias May, (unknown), (unknown), Jana Hutter, (unknown), (unknown), (unknown), Lisa Deloch, (unknown), (unknown), (unknown), Benjamin Frey, Udo S. Gaipl, (unknown), (unknown), Michael Uder, Christoph Bert, (unknown), Florian Putz	0
2	Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders 2025 ·Tarita O. Thomas, Lisa Deloch, (unknown), Richard Shaffer, (unknown), Austin N. Kirschner	0
3	Gender parity in radiation oncology in Germany: a 2024 analysis of professional roles and academic training 2025 ·Strahlentherapie und Onkologie ·(unknown), (unknown), Andrea Wittig, (unknown), Lisa Deloch, (unknown), Birgit Flechl, (unknown), Juliane Hörner‐Rieber, Cordula Petersen, Maike Trommer, (unknown)	0
4	High-dose radiotherapy modulates the expression and secretion of complement (regulatory) proteins by tumor cells 2025 ·Immunobiology ·(unknown), (unknown), Lisa Deloch, Rainer Fietkau, Udo S. Gaipl, Michael Rückert	0
5	German radiation oncology’s next generation: a web-based survey of young biologists, medical physicists, and physicians—from problems to solutions 2024 ·Strahlentherapie und Onkologie ·Thomas Weißmann, Lisa Deloch, (unknown), Maike Trommer, Alexander Fabian, Felix Ehret, (unknown), Alexander Rühle, Sebastian Lettmaier, Florian Putz, (unknown), Simone Wegen, Johann Matschke, Elena Sperk, (unknown)	1
6	Effect of micro- and nanoplastic particles on human macrophages 2024 ·Journal of Hazardous Materials ·(unknown), (unknown), Michael Rückert, Lisa Deloch, Carola Meier, Thomas Tschernig, Christoph Alexiou, (unknown), Anja F. R. M. Ramsperger, Christian Laforsch, Udo S. Gaipl, (unknown), Friedrich Paulsen	29
7	Kleine Dosis – große Wirkung? Der Einsatz von Niedrigdosisbestrahlung (LDRT) bei Alzheimer-Demenz (AD) 2024 ·Strahlentherapie und Onkologie ·(unknown), (unknown), Rainer Fietkau, Lisa Deloch	0
8	Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume Design 2023 ·Cancers ·Thomas Weißmann, (unknown), Matthias May, Sebastian Lettmaier, (unknown), Lisa Deloch, (unknown), (unknown), Benjamin Frey, Udo S. Gaipl, Christoph Bert, Luitpold Distel, Franziska Walter, Claus Belka, Sabine Semrau, Heinrich Iro, Rainer Fietkau, Yixing Huang, Florian Putz	1
9	Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects—challenges for future studies 2023 ·Strahlentherapie und Onkologie ·Thomas Weißmann, Michael Rückert, Florian Putz, Anna-Jasmina Donaubauer, Markus Hecht, (unknown), Philipp Schubert, Johannes Roesch, (unknown), Oliver J. Ott, Marlen Haderlein, Sebastian Lettmaier, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl, Lisa Deloch	11
10	The various functions and phenotypes of macrophages are also reflected in their responses to irradiation: A current overview 2023 ·International review of cell and molecular biology ·Lisa Deloch, Michael Rückert, Thomas Weißmann, Sebastian Lettmaier, (unknown), (unknown), (unknown), Rainer Fietkau, Udo S. Gaipl	1
11	Radon Improves Clinical Response in an Animal Model of Rheumatoid Arthritis Accompanied by Increased Numbers of Peripheral Blood B Cells and Interleukin-5 Concentration 2022 ·Cells ·Lisa Deloch, Stephanie Hehlgans, Michael Rückert, Andreas Maier, (unknown), (unknown), (unknown), Thomas Weißmann, Michaela Seeling, Falk Nimmerjahn, Rainer Fietkau, Franz Rödel, Claudia Fournier, Benjamin Frey, Udo S. Gaipl	5
12	Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts 2022 ·Strahlentherapie und Onkologie ·(unknown), (unknown), (unknown), Lisa Deloch, Udo S. Gaipl, (unknown), Rainer Fietkau, Luitpold Distel, Markus Hecht, (unknown)	15
13	Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients 2022 ·Frontiers in Immunology ·Thomas Weißmann, Michael Rückert, Jian‐Guo Zhou, Michaela Seeling, Sebastian Lettmaier, Anna-Jasmina Donaubauer, Falk Nimmerjahn, Oliver J. Ott, Markus Hecht, Florian Putz, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl, Lisa Deloch	20
14	Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells 2021 ·International Journal of Molecular Sciences ·Sebastian Wimmer, Lisa Deloch, Michael Häder, Anja Derer, (unknown), Thomas Weißmann, Markus Hecht, Antoniu‐Oreste Gostian, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl	12
15	Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment 2019 ·Frontiers in Oncology ·Christoph Seitz, Michael Rückert, Lisa Deloch, Eva‐Maria Weiss, Sebastian G. Utz, (unknown), (unknown), Eberhard Schlücker, Rainer Fietkau, Udo S. Gaipl, Benjamin Frey	16
16	Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies 2018 ·Strahlentherapie und Onkologie ·Michael Rückert, Lisa Deloch, Rainer Fietkau, Benjamin Frey, Markus Hecht, Udo S. Gaipl	85
17	Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation 2016 ·Frontiers in Oncology ·Lisa Deloch, Anja Derer, Josefin Hartmann, Benjamin Frey, Rainer Fietkau, Udo S. Gaipl	112
18	Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses – Pre-Clinical Evidence and Ongoing Clinical Applications 2015 ·Frontiers in Immunology ·Anja Derer, Lisa Deloch, Yvonne Rubner, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl	90
19	Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells 2014 ·Journal of Immunotoxicology ·(unknown), Yvonne Rubner, Lisa Deloch, (unknown), Benjamin Frey, Rainer Fietkau, Jan Dörrie, Niels Schaft, Udo S. Gaipl	62
20	Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling 2012 ·Annals of the Rheumatic Diseases ·Alfiya Distler, Lisa Deloch, Jingang Huang, Clara Dees, Neng‐Yu Lin, Katrin Palumbo‐Zerr, Christian Beyer, Alexander Weidemann, Oliver Distler, Georg Schett, Jörg H. W. Distler	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact